(Q29547903)

English

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

scientific article (publication date: 2009)

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial (English)

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

phase III clinical trial

0 references

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

placebo-controlled trial

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

Yoon-Koo Kang

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Zhendong Chen

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Chao-Jung Tsao

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shukui Qin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jun Suk Kim

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Rongcheng Luo

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jifeng Feng

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Shenglong Ye

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Tsai-Sheng Yang

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jianming Xu

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Yan Sun

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Houjie Liang

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jiwei Liu

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jiejun Wang

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hongming Pan

17

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Karin Burock

18

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Jessie Zou

19

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Dimitris Voliotis

20

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Zhongzhen Guan

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

publication date

16 December 2008

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Lancet Oncology Commission

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

10

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

25-34

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Global cancer statistics in the year 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

International trends and patterns of primary liver cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

The Gambia Liver Cancer Study: Infection with hepatitis B and C and the risk of hepatocellular carcinoma in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment modalities for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated treatment approach to hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of hepatocellular carcinoma in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical practice guidelines for hepatocellular carcinoma: the first evidence based guidelines from Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural history of untreated nonsurgical hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New therapies for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

BAY 43-9006 inhibition of oncogenic RET mutants

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery and development of sorafenib: a multikinase inhibitor for treating cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Spreds, inhibitors of the Ras/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

High serum vascular endothelial growth factor levels predict poor prognosis after radiofrequency ablation of hepatocellular carcinoma: importance of tumor biomarker in ablative therapies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1 alpha

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Platelet-derived growth factor receptor-alpha: a novel therapeutic target in human hepatocellular cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Sorafenib in advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Uncovering Pandora's vase: the growing problem of new toxicities from novel anticancer agents. The case of sorafenib and sunitinib.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk of hand-foot skin reaction with sorafenib: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of the etiology of viral cirrhosis on the survival of patients with hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II study of sorafenib in patients with advanced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver transplantation for hepatocellular carcinoma in Asia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Economic evaluation of sorafenib in the treatment of hepatocellular carcinoma in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Do oncologists believe new cancer drugs offer good value?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

What does the value of modern medicine say about the $50,000 per quality-adjusted life-year decision rule?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2808%2970285-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(08)70285-7

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

3 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=19095497

23 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19095497%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29547903&oldid=1510060198"